Login
- A -
Austria- B -
Belgium- D -
Denmark- F -
FinlandFrance
- G -
GermanyGreece
- I -
Ireland (Eire)Italy
- N -
NetherlandsNorway
- P -
Portugal- S -
SpainSweden
Switzerland
- U -
United Kingdom
Population (2004)
4m
GDP (PPP data, 2004)
$126.4bn
Health expenditure (2004)
Health expenditure as proportion of GDP (2002)
Size of pharmaceutical market (sales, 2004)
Percentage of health expenditure spent on pharmaceuticals (2002)
Pharmaceutical Expenditure per capita (PPP)
Pharmaceutical market growth rate (2004)
Local currency
Euro (€)
Summary: Ireland (Eire)
An agreement between the Irish pharmaceutical industry and the Republic of Ireland government regulates the price of medicines, but guarantees state reimbursement. Patients who can afford it are expected to contribute significantly towards the cost of their treatment.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
31/10/2005
Nurses to prescribe in Ireland
01/08/2005
Pricing Agreement between the IPHA and the DoH expires
06/04/2005
2005 Health Service Executive Plan published
Related Items